You have 9 free searches left this month | for more free features.

masitinib

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV 2, COVID-19, Coronavirus Disease 2019 Trial in France (Masitinib, Isoquercetin, Best Supportive Care)

Recruiting
  • SARS-CoV 2
  • +2 more
  • Masitinib
  • +2 more
  • Aix-en-Provence, France
  • +5 more
Jun 20, 2022

Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)

Recruiting
  • Indolent Systemic Mastocytosis
  • Masitinib
  • +2 more
  • Rochester, Minnesota
  • +6 more
Nov 29, 2021

Metastatic Castrate Resistant Prostate Cancer Trial in Worldwide (Masitinib, Docetaxel, Prednisone)

Completed
  • Metastatic Castrate Resistant Prostate Cancer
  • Masitinib
  • +3 more
  • Sherbrooke, Canada
  • +8 more
Jun 3, 2021

Colorectal Cancer Metastatic Trial in Worldwide (Masitinib)

Completed
  • Colorectal Cancer Metastatic
  • Masitinib
  • Olomouc, Czechia
  • +4 more
Dec 7, 2020

Asthma Trial in Worldwide (Masitinib, Placebo)

Completed
  • Asthma
  • Masitinib
  • Placebo
  • Pleven, Bulgaria
  • +7 more
Feb 9, 2021

Alzheimer Trial in Worldwide (Masitinib, Placebo)

Completed
  • Alzheimer Disease
  • Masitinib
  • Placebo
  • Varna, Bulgaria
  • +5 more
Dec 7, 2020

Asthma Trial in Worldwide (Masitinib, Placebo)

Completed
  • Asthma
  • Masitinib
  • Placebo
  • Buenos Aires, Argentina
  • +4 more
Dec 7, 2020

Gastrointestinal Stromal Tumors Trial in Worldwide (Masitinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Saint Louis, Missouri
  • +4 more
Dec 7, 2020

Ovarian Cancer Trial in Worldwide (Masitinib, Gemcitabine, Placebo)

Completed
  • Ovarian Cancer
  • Masitinib
  • +2 more
  • Algiers, Algeria
  • +5 more
Dec 7, 2020

Locally Advanced or Metastatic Pancreatic Cancer Trial in Worldwide (Masitinib, Gemcitabine, Placebo)

Completed
  • Locally Advanced or Metastatic Pancreatic Cancer
  • Masitinib
  • +2 more
  • Brugge, Belgium
  • +8 more
Dec 7, 2020

Metastatic Melanoma Trial in Worldwide (Masitinib, Dacarbazine)

Terminated
  • Metastatic Melanoma
  • Charlotte, North Carolina
  • +8 more
Nov 3, 2020

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapse Free Trial in

Completed
  • Multiple Sclerosis, Secondary Progressive
  • +2 more
  • Masitinib
  • Placebo
  • Sofia, Bulgaria
  • +7 more
Apr 3, 2020

Indolent Systemic Mastocytosis Trial in France, United States (Masitinib, Placebo, Best Supportive Care)

Completed
  • Indolent Systemic Mastocytosis
  • Masitinib
  • +2 more
  • Sacramento, California
  • +23 more
Nov 29, 2019

Gastrointestinal Stromal Tumors Trial in France, Lebanon, United States (Masitinib, Imatinib)

Terminated
  • Gastrointestinal Stromal Tumors
  • Orlando, Florida
  • +42 more
Dec 2, 2019

Gastro-Intestinal Stromal Tumour Trial (Masitinib, Placebo)

Terminated
  • Gastro-Intestinal Stromal Tumour
  • Masitinib
  • Placebo
  • (no location specified)
Dec 12, 2018

Gastro Intestinal Stromal Tumor Trial in Villejuif (masitinib, sunitinib)

Completed
  • Gastro Intestinal Stromal Tumor
  • Villejuif, France
    Institute Gustave Roussy (IGR)
Dec 8, 2018

Multiple Sclerosis Trial (masitinib)

Completed
  • Multiple Sclerosis
  • masitinib
  • (no location specified)
Dec 8, 2018

Rheumatoid Arthritis Trial (masitinib)

Completed
  • Rheumatoid Arthritis
  • masitinib
  • (no location specified)
Dec 12, 2018

Mastocytosis Trial (masitinib)

Completed
  • Mastocytosis
  • masitinib
  • (no location specified)
Dec 6, 2018

Psoriasis Trial (Masitinib, Placebo)

Completed
  • Psoriasis
  • Masitinib
  • Placebo
  • (no location specified)
Dec 6, 2018

Multiple Myeloma Trial in France, United States (Masitinib, Placebo, Bortezomib)

Terminated
  • Multiple Myeloma
  • Masitinib
  • +3 more
  • Galesburg, Illinois
  • +12 more
Dec 17, 2018

Pancreatic Cancer Trial in Worldwide (Masitinib, Placebo, Gemcitabine)

Completed
  • Pancreatic Cancer
  • Masitinib
  • +2 more
  • Norwich, Connecticut
  • +67 more
Dec 13, 2018